Vorsitz: S. Baldus (Hamburg), P. Stawowy (Berlin)
| (V1520) | Suppressor of Cytokine Signaling-1 Controls Early Murine Atherosclerosis by Regulating Pro-Atherogenic Ly-6Chi Monocyte and Macrophage Formation |
| C. Grothusen, H. Schütt, A. Hillmer, M. Luchtefeld, K. Grote, M. Ballmaier, A. Bleich, S. Glage, U. J. F. Tietge, B. Schieffer (Kiel, Hannover; Groningen, NL) | |
| (V1521) | Vascular dysfunction is mediated by IL-17 driven inflammation in a transgenic mouse model of psoriasis |
| S. Karbach, A. Croxford, F. Kurschus, S. Wörtge, A. Nikolaev, K. El Malki, D. Minwegen, P. Wenzel, M. Oelze, A. Daiber, M. Waldner, M. F. Neurath, H. Li, C. Brochhausen, S. Rose-John, J. Scheller, I. Bechmann, T. Wunderlich, E. von Stebut, T. Münzel, A. Waisman (Mainz, Erlangen, Kiel, Leipzig, Köln) | |
| (V1522) | Der orphan Rezeptor GPCR5B induziert Inflammation in glatten Gefäßmuskelzellen |
| A. Nollert, I. Abu-Taha, N. M. Wolf, M. Lüdde, H. A. Katus, J. Waltenberger, T. Wieland, H.-J. Hippe (Heidelberg, Mannheim, Kiel, Münster) | |
| (V1523) | PHD-2 knockout promotes plaque progression via increased PSGL-1 and VLA-4 expression in granulocytes and monocytes |
| C. Pflücke, M. Christoph, K. Ibrahim, M. Mensch, K. Franke, G. Simonis, B. Wielockx, R. H. Strasser, D. M. Poitz (Dresden) | |
| (V1524) | Role of Angiopoietin-2 mediated hypercirculation in a murine model of LPS- induced sepsis |
| V. Pfetsch, T. Ziegler, J. C. Horstkotte, C. Schwab, I. Rohwedder, R. Hinkel, S. Dietzel, U. Deutsch, C. Kupatt (München, Siegburg, Martinsried; Bern, CH) | |
| (V1525) | TAK1 is proinflammatory and promotes endothelial cell proliferation, migration and angiogenesis |
| N. Zippel, E. Bess, B. Fißlthaler, I. Fleming (Frankfurt am Main) |